Chief Executive Officer @ (November 2019 - October 2022)
Vice President, Global Commercial Disease Leader, CART @ (May 2018 - October 2019)
Global Program Head, CTL019 Lymphoma @ (September 2015 - June 2017)
Executive Director, Global Commercial Strategy, Chimeric Antigen Receptor T Cell (CART) Therapies @ (January 2015 - August 2015)
Executive Director, CV Marketing, Brand Max and Established Medicines @ (March 2013 - December 2014)
Project Leader @ (September 2005 - January 2008)
Will Chou Education
Yale University
Master of Business Administration
2004-2005
University of Pittsburgh
Doctor of Medicine (Medicine)
1995-1999
Will Chou Skills
Marketing Strategy
Sales Management
Business Strategy
Strategic Financial Planning
Sales Operations
Organizational Design
Business Analysis
Public Speaking
Pharmaceutical Industry
Leadership
Clinical Development
Internal Medicine
Geriatrics
Marketing
Management
Pharmaceutical Sales
Product Launch
Strategy
Cross-functional Team Leadership
Managed Care
Sales Effectiveness
Cart
Cross Functional Team Leadership
Will Chou Summary
Will Chou, based in Maplewood, NJ, US, is currently a Chief Executive Officer at Passage Bio. Will Chou brings experience from previous roles at Aruvant and Novartis. Will Chou holds a 2004 - 2005 Master of Business Administration @ Yale University. With a robust skill set that includes Marketing Strategy, Sales Management, Business Strategy, Strategic Financial Planning, Sales Operations and more. Will Chou has 3 emails and 6 mobile phone numbers on RocketReach.
Looking for a different Will Chou?
Find contact details for 700 million professionals.